-
Loading metrics
Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand
- Supachaya Sriphoosanaphan,
- Witthawat Pantumongkol,
- Wantanee Kulpeng,
- Chanchai Charonpongsuntorn,
- Tawesak Tanwandee,
- Wattana Sukeepaisarnjaroen,
- Abhasnee Sobhonslidsuk,
- Pisit Tangkijvanich
x
- Published: March 21, 2024
- https://doi.org/10.1371/journal.pone.0300327